Figure S1: Events that result in the alternative inclusion of exonic sequences (A). Fractions of exons that encode disordered protein segments, according to different thresholds for disorder definition (B)
Figure 2: Tissue-specific segments are enriched in disordered binding motifs and are highly conserved Table S3A : Further examples of TS exons mapping to interaction interface from literature. Table S3B : Genes with tissue-specific exons that map to a protein interaction interfaces Table S3C : Genes with tissue-specific exons that contain PTM sites Figure S4 : Genes with tissue-specific exons are enriched in embryonic lethal and disease genes Table S5A : Genes associated with embryonic lethality and genes that were found mutated in cancer are enriched in the genes with tissue-specific exons Figure S1 , related to main figure 1: Different types of alternative exon inclusion and prevalence of disorder in tissue-specific cassette exons. (A) Events that result in the alternative inclusion of exonic sequences. Exonic sequences that are alternatively present in the mature transcripts are colored green. Cassette exons are exons that are alternatively included in, or excluded from, the mature transcripts with their whole length and their inclusion is decided during splicing. Alternative inclusion of terminal exons occurs through the usage of alternative start and termination sites. Mutually exclusive exons (MXEs) are also differentially included with their whole length, but inclusion of one MXE implies exclusion of the other. When there is more than one 5' or 3' splice site, exon borders can differ depending which of these sites is recognized during splicing. Intron retention is the phenomenon where an intron is read out as a part of an exon and included in the mature transcript. Isoforms resulting from the processes on the left differ in the presence of whole exons and those resulting from splice events on the right differ in length of the spliced exon. In our study, we analysed only cassette alternative exons, and distinguished between tissue-specific and other cassette exons. (B) Fraction of exons encoding disordered segment according to different thresholds for disorder definition. The lines show the fraction of exons, which encode disordered protein segments, in the studied sets of exons: Tissue-specific Cassette exons (red line), Other Cassette exons (dark grey line) and Constitutive exons (light grey line). The X-axis shows different thresholds for a fraction of disorder content in a protein segment that were used to define disordered segment. The Y-axis shows a fraction of exons in each set that were encoding disordered segments defined by using different thresholds. For example, the fraction of residues classified as disordered according to the IUPred is on average 0.4 for known disordered proteins in the Disprot database (Sickmeier et al., 2007) . By using this value as a threshold, we observed a similar trend to those presented in Figure 2B : TS Cassette, Other Cassette and Constitutive exons encoded 35%, 25% and 19% disordered segments. Figure S4 , related to main table 1: Genes with tissue-specific exons are enriched in embryonic lethal and disease genes. Fraction of genes with Tissue-specific Cassette exons (TSE columns in the figure) that are associated with embryonic lethality (A) or cancer (B) is significantly higher than the fraction of all other human genes associated with these (Non TSE columns in the figure). *** denotes p<1.2x10
Figure S2: Evolutionary conservation of whole exons at the level of nucleic acids (A) and amino acids (B). dN/dS (C), dN (D) and dS (E) for the different sets of exons. Evolutionary conservation of disordered region (F) and binding motif (G) at the nucleic acid level. dN/dS (H), dN (I) and dS (J) for binding regions and other regions in TS exons.

Figure S3: Centrality measures for the different gene sets (A), Averaged Jaccard similarity index for all pairs of tissues (B), Monte-Carlo simulation results for the different gene sets (C), Entropy calculation for quantifying variation in interaction partner across different tissues for the different groups of genes (D).
-8 and * denotes p<6.2x10 -2 ; Chi-square test.
Supplemental Tables   Table S1A,B,C,D Table S2 , related to main figure 3 Table S3A ,B,C, related to main figure 4 Table S3B : Genes with tissue-specific exons that map to protein interfaces. Residues in Tissue-specific Cassette exons that were involved in forming an interface in a protein complex are listed. The interfaces that were formed between the protein with TS segment and other proteins, DNA or RNA in the complex were examined. The column 'Protein ID' shows UniProt protein identifiers for the proteins with TS segments, the column 'PDB ID' gives PDB identifiers of the examined complexes, the column 'Chain' shows names of the reference chains in the PDB structures. Finally positions of residues in PDB structures, which form both predicted biologically relevant interface and crystal-contact interface (as obtained from the PISA database) are given. All residues listed in the table are obtained from the PISA database, and those amino acid residues for which difference in accessible surface area (ASA) between complex and monomer in a PDB biological unit was greater than 10% of the amino acid radius, i.e. residues that are more likely to have a role in biological interactions, are marked with a star. (ASA was calculated with Areaimol (http://www.ccp4.ac.uk/html/areaimol.html) and criteria for interface definition was taken from (Levy, 2010) B 11, 19, 21, 22, 23, 27, 28, 29, 30, 34, 38, 54, 56, 57, 67, 70, 71, 82, 84, 85, 95, 97, 98, 99, 100, 102, 105, 114, 115, 129, 130, 131, 135, 136, 137, 138, 139, 148, 150, 151, 161, 162, 163, 164, 165, 167, 168, 171, 175, 178 GMFG 3L50 A 35, 41, 43, 44, 45 59, 62, 63, 64, 65, 66, 67, 68, 69, 71, 72, 73, 79 MASP1 3DEM A 2, 3, 5, 12, 36, 38, 39, 46, 47, 49, 50 HMDH 1DQ8 A 80, 81, 82, 83, 85, 87, 88, 89, 90, 91, 92, 94, 106, 112, 113, 114, 117, 121 PHF8 3KV4 A 59, 104, 145, 177, 184, 424, 430 SAE1 1Y8Q A 251, 253, 254 ERCC1 2A1J B 20, 21, 24, 31, 34, 35, 38, 39, 41 CLM8 2Q87 A 2, 4, 5, 7, 9, 13, 15, 17, 22, 23*, 36, 37, 38, 49, 56, 74, 76, 77, 78, 89, 91, 92, 94, 95 ,4,8,9,10,11,14,15,17,19,21,25,38,39,40,41,42,43,44,45,52, 56,60 C 4, 6, 7, 9, 18, 27, 104, 105 CRYL1 3F3S A 92, 107, 108, 110, 111 RFFL 1Y02 A 23, 24, 25, 28, 29, 50, 54, 55, 58, 66, 68, 69, 71, 73, 76, 77, 78, 83, 86, 87, 88, 89, 91 DHR11 1XG5 C 211, 215, 224 TRMB 3CKK A 42, 51, 53, 57, 60, 61, 63, 64, 65, 67, 69 2, 3, 4, 5, 7, 8, 9, 15, 19 FKBP5 1KT0 A 171, 176, 177, 180, 181, 186, 187 DUS10 2OUC A 6, 10, 13, 23, 35, 36, 38, 40, 41, 42, 43, 44, 45, 47, 53, 57, 58, 61, 62, 63, 64, 65, 68, 69, 72, 82, 88, 90, 91, 92, 93, 104, 105, 106 MKNK1 2HW6 A 203, 204, 208, 223, 224, 226 SAR1A 2GAO B 33, 35, 36, 37, 39 SIRT6 3PKI A 11, 12, 14, 31, 45, 46 THIK 2IIK A 242, 258, 261, 263, 264, 271, 273, 275, 295 FLT3L 1ETE A 110, 113, 114, 118, 121, 122, 123, 126, 131, 133 66,68,71,72,84,99,102*,155,293,297,298,299,302*,306, 308*,361,368,374,375,450,454,455,473 *  IMDH2  1B3O  A  89,93,96  I13R1  3BPN  C  48,49,75,77*,83,93  DUS22  1WRM  A  49,51,52  PDLI1  2PKT  A 35, 36, 37, 46, 47, 55, 56, 57, 64, 68, 70, 73, 76, 77 GAK 3LL6 B 136, 176, 177, 178, 179, 180, 185, 186 ,187  LAP2  1N7T  A  37  PACN2  3HAJ  A  165,166,169,252,256  GALE  1EK5  A  291  PTGR2  2ZB4  A 191, 192, 195, 196, 199, 210, 211, 219, 223, 244 IF4A2 3BOR A 52, 69, 70, 71, 72, 84, 87 PEX19 3AJB B 11, 12, 14, 15, 18, 20, 22 ,24*,25*,26* TRI37 3LRQ A 9*,10,13*, 14, 17, 18, 19, 21, 24, 25, 27*, 28, 30*, 32*, 33, 38, 42 CLK2 3NR9 B 2, 3, 4, 5, 6, 7, 8, 12, 13, 17, 19, 23 A 5,6,9,10,11,12,13,14,15,16,18,20,29,32,33,34,36,37,38, 40,41,44 35, 37, 42, 46, 49, 52, 54, 55, 59, 60, 61, 62, 67, 74, 81, 82, 84, 91, 92, 94, 100, 111, 118, 119, 127, 128, 146, 147, 150, 151, 154, 155, 180, 219, 220, 221, 231, 235, 237, 242, 248, 249, 250, 254, 256, 258, 259, 261 BIRC6 3CEG A 189, 190, 196, 198, 199, 202 KAPCA 3AGL A 247, 250, 268, 269, 276, 286, 300 ZFYV9 1DEV B 4, 6, 7, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 27, 28, 32, 33, 34, 35, 36, 37, 38, 39 -262 154,198,192,195 ENST00000302979 POLR1D breast brain 0.50 1-8 1 Table S4A ,B,C, related to main figure 5 -525,763-783,385-393,839-847,420-429,205-209,457-484,583-600,570-581,541-563,663-672,799-807,713-723,283-292,220-258,406-412,744-753,611-621,686- 35-38, 45, 96-98, 101-103, 109-110, 119-147, 152-152, 162-164, 203-209, 211-277, 282-311, 355-355, 361-363, 365-382, 399-399, 389-389, 401, 406, 410- 70-73, 77-78, 91-93, 100-101, 104-107, 120-122, 126-126,130-131, 133-135, 143-145, 147-150, 156-160, 165 -10, 22, 26-38, 41-63, 65-168, 170-174, 177-178, 189-300, 336-337, 313-315, 318, 321-322, 324 Table S5A,B, related to main table 1   Table S5A : Genes associated with embryonic lethality and genes that were found to be mutated in cancer are enriched in the genes with tissue-specific exons. Genes with tissue-specific isoforms were compared to all other human genes mapped to mouse orthologs that had one or more phenotypes associated to it (as obtained from the Mouse Genome Informatics -MGI database) or to all other human genes with Hugo nomenclature (HGNC) identifiers (as obtained from the Ensembl version 54), in order to asses whether the genes associated with embryonic lethality or genes found to be mutated in cancer, respectively, were enriched in the genes with tissue-specific isoforms. The column N total shows the number of genes that were successfully mapped to the identifiers in the underlying disease gene databases. The column N + shows the number of genes with tissue-specific isoforms or all other genes in the database that were implicated in the disease, as applicable, and N -those that were not annotated as such. Genes that were found mutated in cancer cells were obtained from the COSMIC database. p-values were calculated with the Chi-Square test in R. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Exon dataset TS Cassette exons were composed by mapping cassette exons with differential tissue inclusion levels, as reported by Wang and co-workers, to Ensembl protein coding exons (release 54; www.ensembl.org). Wang et al. reported exons as differentially included if the exon inclusion and exclusion levels, calculated from sequencing reads that mapped to the exon, surrounding exons and exon junction, significantly differed between at least two tissues. The tissues investigated include adipose, brain, breast, cerebellum, colon, heart, liver, lymph node, skeletal muscle and testes; as well BT474, HME, MB435, MCF7 and T47D cell lines. In our study, a TS exon was mapped to a previously annotated exon if the difference between the coordinates (i.e. start or end) of the reported TS exons and coordinates of known and predicted Ensembl protein coding exons was at most two nucleotides. The set of Other Cassette exons was composed from the protein coding Ensembl exons that fulfilled the following criteria: the exon was (i) alternatively present in at least two transcripts with its whole length, (ii) not mutually exclusive with an adjacent exon and (iii) there was another RNA isoform that also contained different exons upstream and downstream of the exon of interest. The latter was a necessary condition to avoid cases of alternative start and termination sites. Exons that overlapped with TS Cassette exons were excluded from the set of Other Cassette exons. It should be noted that the set of Other Cassette exons used here might contain as yet uncharacterized tissue-specific exons. A set of Constitutive exons was composed from the protein coding Ensembl exons that were present in all transcript products with their whole length and with unchanged boundaries. Each exon was associated with the longest protein-coding transcript that contained it. Only transcripts with two or more exons were considered in the study.
Mapping of Pfam domains
We used Pfam software (Finn et al., 2010) for both comparisons, Chi-square test). However, when a protein domain already overlapped a TS segment, it was more common that the segment contained a whole domain compared to when a domain overlapped a segment encoded by Other Cassette or Constitutive exons: 11% (or 72/628) of domain overlaps with a TS segment were cases of a segment containing the full domain, compared to 8% (or 489/6216) for Other Cassette and 8% (or 6088/75355) for Constitutive exons; p<10 -3 and p<10 -3 , Chi-square test.
Disorder prediction with the VSL2 method
To control for the potential bias in the disorder prediction method, we also carried out prediction of disordered regions using the VSL2B software (Peng et al., 2006) . VSL2B is a baseline predictor of the VSL2 method, which uses support vector machine method for the prediction of disordered residues. The method is trained on well-characterized disordered proteins and the VSLB2 application takes into account only amino acid composition of a protein. This makes it faster than the main VSL2 method and hence it is recommended for genome-scale studies (Peng et al., 2006) . Since the prediction method recognizes only symbols for standard 20 amino acids, we removed all non-standard symbols (positions with ambiguously assigned amino acids) from the sequences. After the prediction was carried out, we assigned to the removed amino acids, the same status as the surrounding amino acids (disorder or order) had. Prediction of intrinsically disordered residues by this method confirmed that protein segments encoded by Tissue-specific exons were significantly enriched in disordered residues compared to the segments encoded by Other Cassette and Constitutive exons. The fraction of TS exons that encoded intrinsically disordered proteins segments was 53% (756/1426), which was significantly higher than the fraction of Other Cassette -43% (5958/13,755) or 046) exons that encoded disordered segments; p<2.6x10 -12 and p<2.2x10 -16 , respectively, Chisquare test.
Control calculations for exon length and dataset size
Datasets of exons that we composed for the comparison with Tissue-specific exons were of different size than the set of TS Cassette exons, and exons in them did not have the same distribution of lengths as Tissue-specific exons. To control whether our observations were independent of these dataset traits, we composed smaller subsets of Other Cassette and Constitutive exons that were closer to the traits of Tissue-specific exons. Distribution of lengths of Tissue-specific exons did not follow the normal distribution (p<2.2x10
-16 , Shapiro test), and the median length of the encoded protein segments was 44 amino acids, which was longer than the median lengths of the segments encoded by Other Cassette and Constitutive exons: 34 and 41 amino acids, respectively. We therefore composed sets of Other Cassette and Constitutive exons that had the same median length of the encoded protein segments as Tissue-specific exons: for this we excluded all exons in the complete sets that encoded segments which were shorter than 25 and 21 amino acids, respectively. This left us with 9,074 Other Cassette and 120,412 Constitutive exons. From each of these datasets, we randomly chose 1,426 exons, i.e. we composed exon datasets of the same size as the set of Tissue-specific exons and noted the characteristics of the protein segments encoded by these exons: fraction of disordered segments, fraction of segments with an interaction motif and fraction of segments with a PTM site (Tables S1E). We repeated the random sampling procedure 1,000 times. To compare the distribution of values for the random subsets of filtered Other Cassette and Constitutive exons with the fraction of TS segments that were disordered, had a binding motif or a PTM site, we used cumulative probability distribution function in R (Ross Ihaka, 1996) . P values for each of the examined characteristics were calculated as P (X >= x) = f (x, µ, σ) where f (x, µ, σ) was the probability density function of the normal distribution with mean µ and standard deviation σ. µ and σ were estimated from the random subsets of exons. The density function thus provides the probability that a value greater than or equal to x is observed by chance, given the observed distribution of values. Normal distribution of values in the randomly chosen subsets of exons was examined with the Shapiro-Wilk test in R. Results of this analysis showed that TS segments were indeed enriched in all of the examined characteristics. Results, together with the associated p-values, are in Table S1E .
Calculation of conservation of exons in the three different sets of exons
For the representative protein sequences with segments encoded by TS Cassette, Other Cassette and Constitutive exons, we compared conservation between human and mouse protein segments as well between DNA regions encoding these segments, i.e. coding residues in these exons. For the comparison, only one-toone human-mouse orthologs were considered and this information was obtained from Ensembl 54, which was initially used for mapping exon coordinates to protein segments. Coding DNA and protein sequences of protein pairs were aligned with Needleman-Wunsch algorithm (from the Emboss package: http://emboss.sourceforge.net/, default settings both for protein and DNA alignments). Conservation values were analyzed only for segments longer than 10 amino acids which were present in the orthologous mouse proteins; criteria for this was that more than 90% of the segment was aligned to the orthologous mouse sequence. For these segments, we calculated percentage of identical residues in mouse orthologs from protein pairwise alignments. We also performed the same calculation for predicted disordered regions in these protein segments only, as well as a separate analysis for the predicted binding motifs and all other residues in these protein segments. We performed analogous calculations for the corresponding residues in DNA alignments. Distribution of values between different groups was compared with Mann-Whitney test in R.
Next, we extracted segments from the protein alignments that corresponded to the analyzed exons, and we also extracted DNA sequence regions that encoded the aligned human and mouse protein segments. We performed reverse alignment from the R seqinr package to align DNA sequences based on the protein alignments and used kaks function in the R seqinr package to calculate Ka and Ks values for each segment. Additionally, for tissue-specific segments that contained predicted binding motifs, we divided residues based on whether they belonged to a motif or not and calculated Ka and Ks values for these sub-regions in TS segments.
Measurements of network centrality in TSE-containing genes
The use of a network formalism to describe biological interactions enables the use of many tools from graph theory. In particular, it permits us to assess the "topological importance" that a single node (e.g. protein) has in an interaction network. For instance, what will be the impact of removing a given protein from the network? How critical is a protein to maintain a given pattern of interactions? Such notion is encapsulated by the concept of "centrality". Several approaches can be used to assess the centrality of a node in a network. In this case, we used four independent metrics to test whether protein-coding genes with Tissue Specific cassette Exons (TSE genes) tend to occupy central position in the human protein-protein interaction networks (PPI networks). All the following metrics were computed for the entire human protein-protein interaction network, using the "iGraph" package for R (http://igraph.sourceforge.net/).
Betweenness centrality (btc) measures the extent to which a given node connects other nodes in the network, thereby forming a path (Gursoy et al., 2008) . Considering a node v in a network, btc gives the proportion of shortest paths from all nodes to all others that pass through v. The betweenness centrality of a node v is therefore defined as:
where σ st gives the total number of shortest paths between a node s and a node t (both distinct from v), and σ st (v) is the number of such paths that include v.
Closeness centrality (C C ) of a node v is the inverse of "farness", that is the total distance of this node to all other nodes in graph. The further apart a node is from the other nodes in the graph, the closer to zero is its closeness centrality (Sabidussi, 1966) . More formally, closeness centrality is defined as:
where t∈V denotes any node belonging to the network, and d(v,t) the shortest distance between v and t.
PageRank. The PageRank algorithm is commonly known as a core component of the Google search engine (Sergey Brin, 1998), but its usefulness and relevance for biological networks has been recently illustrated (Ivan and Grolmusz, 2011) , and implementations of the algorithm can be found in statistical network analysis packages such as iGraph. In the context of a protein-protein interaction network, the algorithm iteratively assigns a score to each protein based on the connectivity of neighboring nodes it is connected with. A protein will have a high Page rank if it is interacting with many highly connected proteins.
Kleinberg's Hub score. This algorithm, based on the concept of 'hubs and authorities' as defined by Kleinberg (Kleinberg, 1999; Kleinberg, 2000) is a precursor of the PageRank algorithm. Given a graph G, the hubs of G are determined through the adjacency matrix A of G, by computing the eigenvectors of the product AA T . Based on this, the relative importance of each protein is computed taking into account the hub score of its interacting partners. The more hubs are connected to a protein, the higher is its score.
These four metrics were computed for all individual proteins of the human protein-protein interaction network, and the distributions of (i) TSE genes with predicted binding motif, (ii) other TSE genes and (iii) genes without TSE were compared, using a non-parametric test (Mann-Whitney test). Results of each measurement are provided in Figure S3A . Jaccard similarity index and the comparison of tissue-specific interaction landscapes of TSE and non-TSE genes Genes with tissue-specific splicing isoforms were taken from Wang et al, 2008 . By definition, such genes have one isoform containing a cassette exon that is significantly more included (in relative abundance, compared to the other isoforms of the same gene) in some tissues than in others. These tissue-specific splice isoforms are therefore considered either "included" or "excluded" in a given set of tissues. Bossi and Lehner, integrated robust multi-array averaged expression profiles of human genes with protein-protein interactions data to generate a series of tissue-specific protein-protein interaction networks. In this study, the authors assembled a high confidence dataset of known protein-protein interactions based on low throughput and high throughput experiments. The authors discretized tissue-specific mRNA expression levels and accordingly removed nonexpressed genes from their protein-protein interaction network of reference, thereby generating tissue-specific interactomes. Among the 10,230 genes present in the protein interaction network, 8,235 had information on tissue-specific interactions. In particular, more than 60% of TSE genes (n=740) had information on tissuespecific interactions.
Dataset construction
To perform the interaction similarity analysis, we restricted the analysis to tissues overlapping between both Wang et al, 2008 and Bossi and Lehner, 2009 studies, which resulted in 15 human tissues. Noticeably, the correspondence of tissue types across the two studies is incomplete. In particular, the tissue-specific interactomes depict a more detailed repertoire of tissues than the measurements of differential expression of tissue-specific exons. Hence, we restricted our analysis to tissues that could unambiguously be related in both studies, resulting in 9 tissues from Wang et al, 2008 (out of 15) and we related these to 15 tissues from Bossi and Lehner, 2009 (out of 79). In particular, it was assumed that the inclusion levels of tissue-specific exons that were quantified in whole brain and whole testes Wang et al, 2008 -were valid for substructures within testes (i.e. seminiferous tubules, Leydig cells, germ and interstitial tissues) and brain (temporal lobe, cingulate cortex, prefrontal cortex, thalamus).
Principle of the calculation
We used the Jaccard similarity index to quantify the extent to which the interaction partners of a gene are maintained in a pair of tissue. The Jaccard similarity coefficient for a gene g expressed in a pair of tissues A and B was defined as:
where ∩ A,B PPI(g) denotes the common interaction partners of g in tissues A and B, and ∪ A,B PPI(g) denotes the all possible interactions partners of g in tissues A or B. Values span between 0 and 1, where 0 indicates that the interaction partners of g in A and B are strictly different, and a value of 1 indicates that interactions partners of g in A and B are strictly identical.
Data processing
We applied the calculation for all genes in the human protein-protein interaction network, in all pairwise combinations of tissues included in the analysis ( Figure S3B ). We then selected Jaccard similarity indices of genes and pairs of tissues for which in each compared tissue at least one interaction was found, thereby removing ambiguous cases were a gene appears to have tissue-specific partners (Js=0) simply because it is either not expressed in the two tissues, or because none of its interaction partners are expressed.
We then selected the Jaccard similarity indices of TSE genes in the pairs of tissues where isoform inclusion levels were found to be significantly different ("TSE genes", Figure 3D ). We also selected the Jaccard similarity scores of non-TSE genes in the same pairs of tissues used for the "TSE genes" set ("non-TSE genes", Figure 3D ). Further, we selected the Jaccard similarity indices from "TSE genes" for genes with predicted binding motifs of at least 10 amino acids ("TSE with motif", Figure 3D ), and those genes without such motif ("TSE without motif", Figure 3D ).
Monte-Carlo simulation
To test if the observed distributions of Jaccard similarity indices could be expected by chance, we performed a Monte-Carlo simulation employing 100,000 trials, where we randomly re-assigned Jaccard similarity indices to the genes, and computed how many times the random expected mean value of Jaccard indices of a given set of genes was lower than the real mean value observed in the original set. We apply such calculation for 3 sets of genes: (1) non-TSE genes, (2) TSE genes, and (3) TSE genes that contain a predicted binding motif of at least 10 amino acids ( Figure S3C ).
Information entropy of interaction patterns across different tissues
Since TSE genes showed a higher average number of interaction partners in the consensus human protein interaction network (Figure 3A) , as well as in tissues sub-networks where tissue-specific alternative splicing has been observed (Fig 3B) , we investigated whether the interaction partners of TSE genes tend to vary across tissues using another independent metric. We took advantage of existing tools from information theory to quantify how variable are the interaction partners of a gene across the 79 human tissues Bossi and Lehner integrated in their study (Bossi and Lehner, 2009 ).
Principle of the calculation
A simple formalism was used to quantify heterogeneity in the interaction partners that protein-coding genes encounter across multiple tissues, and is illustrated in Figure S3D (left panel).
The status of a given interaction across many tissues can conveniently be described by a vector, made of 1 and 0s that denote the presence or absence of that interaction; each position in the vector corresponding to a defined tissue. Hence, looking at the N interactions partners of a given gene across M tissues simply requires considering N vectors of size M, made of 1 and 0s. In this context, measuring variations of the N interaction partners across multiple tissues becomes equivalent to measuring the dissimilarity of the N vectors all at once. Importantly, one must be able to distinguish not only the number of interactions a gene has in a given tissue (from 0 to N), but also the exact identity of these interactions. An efficient way to maintain such information is to take, for each tissue, the status of each interaction (0 or 1), and form a "letter" with it.
For instance such a vector = "01010" can describe the status of 5 interaction partners of a gene in a given tissue. Hence, a gene will possess M letters in total, and the total number of unique letters for that gene will be p ≤ M. If we note (θ 1, , θ 2, , …, θ p ) the probability of apparition of each letter, then the Shannon entropy can be used to quantify how diverse the letters are, for each gene that has information for tissue-specific interactions. The Shannon entropy is given by:
The higher the Shannon entropy, the more letters one finds in the message, i.e. the more unique sets of interaction partners one finds across the analyzed tissues. We therefore referred to this metric as "interaction entropy". From this calculation we note that TSE genes with binding motifs have higher interaction entropy compared to TSE genes without binding motifs and non-TSE genes ( Figure S3D , right)
Data processing
Genes that had one unique interaction partner across all tissues were removed from the analysis. Since the more interaction partners a gene has, the higher the number of unique words can be generated. Hence, a positive association between entropy and node degree is expected, and was indeed observed (r=0.678, p<2.2x10 -16 , Spearman rank correlation, Figure S3D , middle). We therefore scaled interaction entropy values on a running median to compare the interaction entropy of genes with different node degrees (Figure S3D , middle). As expected, this transformation drastically reduced the correlation between partnership entropy and node degree (-0.047, Spearman rank correlation). Distributions of interaction entropy (and scaled interaction entropy) for the analysed sets of genes were then compared with a Mann-Whitney test (Figure S3D , right) and the differences were found to be significant even after the scaling step. All calculations were performed in the R statistical package, and interaction entropy was computed with the help of the package "entropy" (Xing and Lee, 2006) . Analysis of functional enrichment DAVID (http://david.abcc.ncifcrf.gov) was used to investigate functional enrichment in the different exon categories. Phenotype annotations for mouse genes and the list of genes associated with embryonic lethality were obtained from the Mouse Genome Informatics database (www.informatics.jax.org). The cancer gene census and genes from the COSMIC database (release 43) were downloaded from the corresponding databases at www.sanger.ac.uk/genetics/CGP/. Signaling pathway information was obtained from http://signalink.org.
Tissue-specific disordered regions in transcription factors and kinases
A list of human kinases was obtained from www.kinome.org. Of the 506 investigated human kinases, 45 had a TS segment. Kinases for which TS segments did not overlap a Pfam domain but contained interaction motifs embedded in disordered regions (25 kinases) are provided in Table S14B . A set of human transcription factors (1,391 TFs) was obtained from the literature (Vaquerizas et al., 2009 ) and those TFs that contained TS segments were further investigated (67 TFs). Pfam protein domains were mapped to the encoded protein sequences and those TS segments that did not overlap with any Pfam domains or predicted binding motifs but contained disordered regions are listed in Table S4C (40 TFs) .
